EDEN PRAIRIE, Minn. , July 24, 2024 /PRNewswire/ -- inFormed Consent, a pioneer in digital informed consent and patient education technology, announces its partnership with trifermed, a corporate strategy and business development healthcare solutions company, to introduce the new remote consent capability to its current medical device markets and the new inFormed Consent clinical data platform to clinical research organizations and pharmaceutical companies. trifermed, a Barcelona and Cambridge, MA based company, is recognized as a leader in connecting their clients with clinical research organizations, pharmaceutical companies, and medical device companies.
trifermed will provide strategic and operational support for the launch of the inFormed Consent platform in these markets. One of the biggest challenges clinical research projects face is a lack of patient recruitment for their clinical studies. Approximately 80% of clinical trials are delayed or closed due to challenges related to patient recruitment and consent.
These delays can cost the sponsoring company as much as $600,000 per day when considering the impact of delays on a new product commercial launch. Another challenge faced is collecting clinical data from research sites due to the additional burden placed on the research coordinators. The inFormed Consent platform enables clinical research companies to remotely present information related to a clinical trial, ensures patient understanding, and asks the patient to .